Atrial fibrillation (AFib) is the most common cardiac arrhythmia worldwide and a major contributor to heart failure (HF), ...
The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...
As the global burden of obesity, type 2 diabetes, and metabolic syndrome continues to rise, fatty liver disease has become ...
A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity ...
A diabetes drug may soon double as a treatment for liver disease. Dapagliflozin, an SGLT-2 inhibitor typically used for type 2 diabetes, significantly improved liver inflammation and scarring in ...
The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows improvements for patients with progressive liver disease, finds a clinical ...
A new 2026 study reveals how chronic stress depletes NAD⁺, impairing immunity and accelerating liver cancer—while linking the ...
Your face serves as a remarkable window into your overall health, often revealing internal problems long before you experience obvious symptoms. When it comes to fatty liver disease, one of the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results